Literature DB >> 2036475

Erythrocyte choline concentrations in psychiatric disorders.

A L Stoll1, B M Cohen, I Hanin.   

Abstract

Erythrocyte choline has been used as a potential indirect measure of cholinergic function in the central nervous system (CNS). We review the literature and present some new data on erythrocyte choline concentrations in patients with neuropsychiatric disorders. Our data and most of the reviewed studies report modest elevations in mean erythrocyte choline values in patients with affective illnesses, psychoses, dementia, and other neuropsychiatric disorders when compared to controls. Within each disorder, the increased mean erythrocyte choline concentrations are due to subgroups of patients with especially high values. These subgroups of patients with elevated erythrocyte choline levels appear to have clinical characteristics that distinguish them from patients with normal choline values. Finally, the dramatic rise in erythrocyte choline concentration produced by lithium therapy is reviewed, and the implication of this effect, in particular, the possibility that pretreatment or posttreatment erythrocyte choline concentrations may predict response to lithium, is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2036475     DOI: 10.1016/0006-3223(91)90216-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  3 in total

1.  Release of choline by phospholipase D and a related phosphoric diester hydrolase in human erythrocytes. 1H spin-echo n.m.r. studies.

Authors:  H Selle; B E Chapman; P W Kuchel
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

2.  Lithium does not alter the choline/creatine ratio in the temporal lobe of human volunteers as measured by proton magnetic resonance spectroscopy.

Authors:  P H Silverstone; C C Hanstock; S Rotzinger
Journal:  J Psychiatry Neurosci       Date:  1999-05       Impact factor: 6.186

3.  Brain choline concentrations may not be altered in euthymic bipolar disorder patients chronically treated with either lithium or sodium valproate.

Authors:  Ren H Wu; Tina O'Donnell; Michele Ulrich; Sheila J Asghar; Christopher C Hanstock; Peter H Silverstone
Journal:  Ann Gen Hosp Psychiatry       Date:  2004-07-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.